[Hematodermic CD4+ CD56+ neoplasm in childhood]

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Hematodermic CD4+ CD56+ neoplasm, a rare and aggressive malignancy, is characterized by plasmacytoid dendritic cell phenotype.
• This neoplasm is typically diagnosed in elderly adults, with rare occurrences in childhood.

Observation:

• A 12-year-old girl presented with severe mental retardation, genetic features, and multiple nodular skin lesions on her extremities.
• Histological examination revealed diffuse dermal infiltrates of medium and small cells expressing CD4, CD56, CD43, S100, and plasmacytoid dendritic cell markers (CD123, BDCA-2) via flow cytometry.
• The patient had no peripheral blood or bone marrow involvement.

Findings:

• The pediatric case exhibited characteristic immunophenotypic markers of Hematodermic CD4+ CD56+ neoplasm.
• Cutaneous lesions showed clinical remission within two weeks following treatment with acute lymphoblastic leukemia therapy.

Implications:

• This case highlights the possibility of Hematodermic CD4+ CD56+ neoplasm presenting in childhood.
• The response to acute lymphoblastic leukemia therapy suggests potential therapeutic targets or shared pathways.
• Further research is warranted to understand the biology and treatment of this rare pediatric neoplasm.